<DOC>
	<DOCNO>NCT00974922</DOCNO>
	<brief_summary>This study evaluate effect Vitamin D replacement effect approve medication hypertension , aliskiren ( Tekturna ) , patient high blood pressure low level vitamin D blood . The study compare effect vitamin D aliskiren alone combination 24-hour blood pressure biochemical parameter .</brief_summary>
	<brief_title>Vitamin D Deficiency Patients With Hypertension</brief_title>
	<detailed_description>This study ass whether aliskiren low clinic blood pressure 24-hour blood pressure patient hypertension vitamin D deficiency . Additionally , study explore potential additional effect add vitamin D aliskiren patient population .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Men woman 21 year age history Stage 1 2 hypertension ( define seat diastolic BP â‰¥ 90 mmHg &lt; 110 mmHg untreated state ) . Patients treatment hypertension must willing able discontinue previous antihypertensive medication duration study . 25hydroxyvitamin D level &lt; 30 ng/ml &gt; 12 ng/ml . Women childbearing potential must use medically acceptable form birth control duration trial , must negative serum pregnancy test screening , must negative urine pregnancy test within 7 day initiate aliskiren therapy . Vitamin D level &lt; 12 ng/ml Known hypersensitivity allergy aliskiren Clinic blood pressure &gt; 180/110 mmHg Known form secondary hypertension Chronic atrial fibrillation Uncontrolled unstable cardiovascular disease Shift night worker Midarm circumference &gt; 42 cm diameter Current recent ( &lt; 1 year ) alcohol drug abuse Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Hypertension</keyword>
</DOC>